Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Brierley DJ"'
Publikováno v:
Dental Update; Oct2023, Vol. 50 Issue 9, p724-727, 4p
Publikováno v:
In Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology July 2021 132(1):e50-e51
Publikováno v:
In Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology July 2021 132(1):e11-e11
Autor:
Gorania R; Academic Unit of Oral and Maxillofacial Pathology, The University of Sheffield, Sheffield, UK., Hunter K; Liverpool Head and Neck Centre, University of Liverpool, Liverpool, Merseyside, UK., Hall G; Head and Neck Pathology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Brierley DJ; Academic Unit of Oral and Maxillofacial Pathology, The University of Sheffield, Sheffield, UK d.j.brierley@sheffield.ac.uk.
Publikováno v:
Journal of clinical pathology [J Clin Pathol] 2023 Dec; Vol. 76 (12), pp. 822-826. Date of Electronic Publication: 2022 Sep 06.
Autor:
Stephens-LaBorde IS; Unit of Oral and Maxillofacial Pathology, Floor E, The School of Clinical Dentistry, University of Sheffield, 19 Claremont Crescent, Sheffield S10 2TA, United Kingdom., Brierley DJ; Unit of Oral and Maxillofacial Pathology, Floor E, The School of Clinical Dentistry, University of Sheffield, 19 Claremont Crescent, Sheffield S10 2TA, United Kingdom.
Publikováno v:
The British journal of oral & maxillofacial surgery [Br J Oral Maxillofac Surg] 2022 Jun; Vol. 60 (5), pp. 577-583. Date of Electronic Publication: 2021 Oct 29.
Autor:
Douthwaite JA; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. julie.douthwaite@astrazeneca.com., Brown CA; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK. christopher.brown@crl.com., Ferdinand JR; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Sharma R; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Elliott J; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Taylor MA; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Malintan NT; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Duvoisin H; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hill T; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK., Delpuech O; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Orton AL; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pitt H; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Kuenzi F; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK., Fish S; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.; GSK R&D Tech, Stevenage, UK., Nicholls DJ; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Cuthbert A; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Richards I; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK., Ratcliffe G; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK., Upadhyay A; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Marklew A; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK., Hewitt C; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ross-Thriepland D; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Brankin C; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Chodorge M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Browne G; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mander PK; GSK R&D, Stevenage, UK., DeWildt RM; GSK R&D, Stevenage, UK., Weaver S; GSK R&D Tech, Stevenage, UK., Smee PA; GSK R&D Tech, Stevenage, UK., van Kempen J; GSK R&D, Stevenage, UK., Bartlett JG; GSK R&D, Stevenage, UK., Allen PM; GSK R&D, Stevenage, UK., Koppe EL; GSK R&D, Stevenage, UK., Ashby CA; GSK R&D, Stevenage, UK., Phipps JD; GSK R&D, Stevenage, UK., Mehta N; GSK R&D, Stevenage, UK., Brierley DJ; GSK R&D, Stevenage, UK., Tew DG; GSK R&D, Stevenage, UK., Leveridge MV; GSK R&D, Stevenage, UK., Baddeley SM; GSK R&D, Stevenage, UK., Goodfellow IG; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK., Green C; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Abell C; Vice Chancellor's Office, University of Cambridge, Cambridge, UK., Neely A; Vice Chancellor's Office, University of Cambridge, Cambridge, UK., Waddell I; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK., Rees S; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Maxwell PH; School of Clinical Medicine, University of Cambridge, Cambridge, UK., Pangalos MN; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Howes R; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Clark R; Charles River Laboratories, Chesterford Research Park, Saffron Walden, UK.
Publikováno v:
Scientific reports [Sci Rep] 2022 Feb 24; Vol. 12 (1), pp. 3114. Date of Electronic Publication: 2022 Feb 24.
Autor:
Kendall TJ; Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK. Electronic address: tim.kendall@ed.ac.uk., Robinson M; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Brierley DJ; Unit of Oral and Maxillofacial Pathology, University of Sheffield, Sheffield, UK., Lim SJ; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., O'Connor DJ; The Medicines and Healthcare Products Regulatory Agency, London, UK., Shaaban AM; Queen Elizabeth Hospital Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK., Lewis I; National Cancer Research Institute, London, UK., Chan AW; Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, ON, Canada., Harrison DJ; University of St Andrews, St Andrews, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Oct; Vol. 22 (10), pp. e435-e445.
Autor:
Tailor A; Oral Medicine Unit, Charles Clifford Dental Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hegarty AM; Oral Medicine Unit, Charles Clifford Dental Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Brierley DJ; School of Clinical Dentistry, Academic Unit of Oral and Maxillofacial Medicine and Pathology, Sheffield, UK.
Publikováno v:
British journal of hospital medicine (London, England : 2005) [Br J Hosp Med (Lond)] 2021 Mar 02; Vol. 82 (3), pp. 1-6. Date of Electronic Publication: 2021 Mar 22.
Delphi study to determine the key qualities consultant histopathologists look for in their trainees.
Autor:
Brierley DJ; Unit of Oral and Maxillofacial Pathology, University of Sheffield, Sheffield, UK d.j.brierley@sheffield.ac.uk., Farthing PM; University of Sheffield, Sheffield, UK., Zijlstra-Shaw S; Unit of Oral and Maxillofacial Pathology, University of Sheffield School of Clinical Dentistry, Sheffield, UK.
Publikováno v:
Journal of clinical pathology [J Clin Pathol] 2020 Oct; Vol. 73 (10), pp. 642-647. Date of Electronic Publication: 2020 Apr 10.
Autor:
Phillipou AN; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Lay CS; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Carver CE; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Messenger C; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Evans JP; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Lewis AJ; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Gordon LJ; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Mahmood M; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Greenhough LA; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Sammon D; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Cheng AT; Functional Genomics, Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA, USA., Chakraborty S; Functional Genomics, Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA, USA., Jones EJ; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Lucas SCC; Epigenetics Research Unit, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Gatfield KM; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Brierley DJ; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK., Craggs PD; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
Publikováno v:
SLAS discovery : advancing life sciences R & D [SLAS Discov] 2020 Feb; Vol. 25 (2), pp. 163-175. Date of Electronic Publication: 2019 Dec 25.